Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED
02 1Calyx Chemicals & Pharmaceuticals
03 1Jubilant Pharmova Limited
04 1Professional Compounding Centers of America
05 1Professional Compounding Centers of America dba PCCA
06 1R.L.Fine Chem Private Limited
07 1Spectrum Laboratory Products, Inc.
08 1Sri Krishna Pharmaceuticals Ltd. Unit I
09 1Srikem Laboratories Pvt. Ltd.
10 2Symed Labs Limited
11 1THINQ Pharma-CRO Limited
12 1Xenex Laboratories Inc
01 1MECLIZINE
02 3MECLIZINE HYDROCHLORIDE
03 1Meclizine
04 8Meclizine Hydrochloride
01 1Canada
02 9India
03 1U.S.A
04 2United Kingdom
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-108
Start Marketing Date : 2020-02-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1137
Start Marketing Date : 2008-06-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
MECLIZINE HYDROCHLORIDE ANHYDROUS
NDC Package Code : 51927-0043
Start Marketing Date : 2002-07-19
End Marketing Date : 2025-04-30
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
MECLIZINE HYDROCHLORIDE ANHYDROUS
NDC Package Code : 51927-0228
Start Marketing Date : 2022-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-4390
Start Marketing Date : 2016-04-01
End Marketing Date : 2027-10-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66326-809
Start Marketing Date : 2020-01-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13746-102
Start Marketing Date : 2008-01-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0114
Start Marketing Date : 1982-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0114
Start Marketing Date : 1982-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54469-0002
Start Marketing Date : 2016-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Meclizine hydrochloride anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meclizine hydrochloride anhydrous, including repackagers and relabelers. The FDA regulates Meclizine hydrochloride anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meclizine hydrochloride anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meclizine hydrochloride anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meclizine hydrochloride anhydrous supplier is an individual or a company that provides Meclizine hydrochloride anhydrous active pharmaceutical ingredient (API) or Meclizine hydrochloride anhydrous finished formulations upon request. The Meclizine hydrochloride anhydrous suppliers may include Meclizine hydrochloride anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Meclizine hydrochloride anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Meclizine hydrochloride anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Meclizine hydrochloride anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Meclizine hydrochloride anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Meclizine hydrochloride anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Meclizine hydrochloride anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Meclizine hydrochloride anhydrous suppliers with NDC on PharmaCompass.
We have 11 companies offering Meclizine hydrochloride anhydrous
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
